Home
News
Screeners
Insights
Pentokey Organy
33.
03
0.00
(0.00%)
Market Cap
₹20.70 Cr
PE Ratio
76.81
Industry
Chemicals
Buy
Sell
Company Performance:
1D
0.00%
1M
-5.92%
6M
-6.69%
1Y
-22.74%
5Y
0.00%
View Company Insights
Latest news about Pentokey Organy
Pentokey Organy schedules 39th AGM for September 26, 2026
Sep 07, 2026
Pentokey Organy holds its 39th AGM on September 26, 2026. Meeting conducted via VC/OAVM with remote e-voting enabled. Cut-off date for voting rights is September 19, 2026. Book closure runs from September 20 to September 26.
Pentokey Organy FY26 Results: Revenue up 153%, net profit falls 17%
Sep 03, 2026
Pentokey Organy schedules 39th AGM for September 26, 2026
Aug 13, 2026
Pentokey Organy appoints Kavita Bohra as independent director
Aug 13, 2026
Pentokey Organy Q1 Results: Net Profit Falls 55% To ₹21.73 Lakh
Aug 13, 2026
More news about Pentokey Organy
26
May 26
Pentokey board to consider Q4FY26 results on May 30
Pentokey Organy (India) Limited will hold a board meeting on May 30, 2026, to approve audited financial results for Q4 and FY26. The trading window will reopen 48 hours post-results announcement.
15
Apr 26
Pentokey Organy (India) Limited Files SEBI Compliance Certificate for Q4FY26
Pentokey Organy (India) Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5), reporting 883 shares dematerialized across both depositories with zero rematerializations. The certificate, submitted through registrar Datamatics Business Solutions Ltd, confirms proper processing of all share transfers and adherence to regulatory requirements for the quarter ended 31st March, 2026.
16
Jan 26
Pentokey Organy Board Meeting Scheduled for January 21, 2026 to Review Q3FY26 Financial Results
Pentokey Organy (India) Limited has scheduled a board meeting for January 21, 2026, to consider and approve unaudited financial results for Q3FY26 ended December 31, 2025. The company informed BSE about the meeting in compliance with SEBI regulations. The trading window for company securities, currently closed under insider trading regulations, will reopen 48 hours after the financial results become publicly available.
08
Nov 25
Pentokey Organy Reports Robust Q2 FY26 Performance with 347% Revenue Growth
Pentokey Organy Limited, operating in the Pharma/Pesticides trading segment, announced impressive Q2 FY26 results. Revenue from operations soared 346.95% to Rs. 98.33 lakhs, while total income rose 195.47% to Rs. 108.94 lakhs. Net profit increased by 35.14% to Rs. 14.23 lakhs, with EPS reaching Rs. 0.23. The company's half-year revenue for FY26 stood at Rs. 604.54 lakhs, up from Rs. 22.09 lakhs in the previous year. An unmodified limited review report was issued by the statutory auditors. The company has a pending income tax appeal for Rs. 171.58 lakhs for the assessment year 2015-16.
Pentokey Organy
33.
03
0.0
(0.0%)
1 Year Returns:
-22.74%
Industry Peers
Tata Chemicals
693.25
(-
11.
04
%)
Deepak Fertilisers & Petrochemicals
1,343.20
(+
1.
40
%)
Gujarat Narmada Valley Fert & Chem
588.90
(+
0.
69
%)
TANFAC Industries
3,530.00
(+
0.
09
%)
Gujarat Alkalies & Chemicals
638.70
(-
2.
64
%)
Grauer & Weil
86.62
(+
9.
52
%)
GHCL
421.70
(+
0.
38
%)
Chemplast Sanmar
171.48
(+
2.
19
%)
JG Chemicals
612.40
(+
4.
12
%)
Fischer Medical Ventures
33.15
(-
0.
45
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar